富血小板血浆在慢性疼痛疾病中的应用进展
摘要
关键词
全文:
PDF参考
[1]Caiado A，Ferreira-Dos-Santos G，Gonçalves S，Horta L，Branco PS. Proposal of a new standardized freeze-thawing technical
protocol for leukocyte-poor platelet-rich plasma preparation and cryopreservation. Cureus 2020；12：e8997
[2]Navani A，Li G，Chrystal J. Platelet rich plasma in musculoskeletal pathology：a necessary rescue or a lost cause? Pain Physician
2017；20：E345-E356.
[3]Rendu F，Brohard-Bohn B. The platelet release reaction：granules' constituents，secretion and functions. Platelets 2021；12：261-273.
[4]Bhatia，R.，& Chopra，G.（2016）. Efficacy of platelet rich plasma via lumbar epidural route in chronic prolapsed intervertebral disc
patients-a pilot study. Journal of Clinical and Diagnostic Research.
[5]Bise，S.，Dallaudiere，B.，Pesquer，L.，Pedram，M.，Meyer，P.，Antoun，M. B.，Hocquelet，A.，& Silvestre，A.（2020）.
Comparison of interlaminar CT-guided epidural platelet-rich plasma versus steroid injection in patients with lumbar radicular pain.
European Radiology，30，3152–3160.
[6]Attal，N.（2019）. Pharmacological treatments of neuropathic pain：The latest recommendations. Revue Neurologique，175，46–50.
[6]Bai，L.，Wang，X.，Li，Z.，Kong，C.，Zhao，Y.，Qian，J.-L.，Kan，Q.，Zhang，W.，& Xu，J.-T.（2016）. Upregulation
of chemokine CXCL12 in the dorsal root ganglia and spinal cord contributes to the development and maintenance of neuropathic pain
following spared nerve injury in rats. Neuroscience Bulletin，32，27–40.
[7]Bai，L.，Wang，X.，Li，Z.，Kong，C.，Zhao，Y.，Qian，J.-L.，Kan，Q.，Zhang，W.，& Xu，J.-T.（2016）. Upregulation
of chemokine CXCL12 in the dorsal root ganglia and spinal cord contributes to the development and maintenance of neuropathic pain
following spared nerve injury in rats. Neuroscience Bulletin，32，27–40.
[8]El-Sharkawy，H.，Kantarci，A.，Deady，J.，Hasturk，H.，Liu，H.，Alshahat，M.，& Van Dyke，T. E.（2007）. Platelet-richplasma：Growth factors and pro- and anti-inflammatory properties. Journal of Periodontology
[9]Kuffler，D. P.，& Foy，C.（2020）. Restoration of neurological function following peripheral nerve trauma. International Journal of
Molecular Sciences
[10]Kuffler，D.（2018）. Variables affecting the potential efficacy of PRP in providing chronic pain relief. Journal of Pain Research，12，
109–116.
[11]Akeda，K.，Yamada，J.，Linn，E.，Sudo，A.，& Masuda，K.（2019）. Platelet-rich plasma in the management of chronic low
back pain：A critical review. Journal of Pain Research，12，753–767
[12]Tong，S.，Zhang，C.，& Liu，J.（2017）. Platelet-rich plasma exhibits beneficial effects for rheumatoid arthritis mice by suppressing
inflammatory factors. Molecular Medicine Reports，16，4082–4088.
[13]Tohidnezhad，M.，Bayer，A.，Rasuo，B.，Hock，J. V. P.，Kweider，N.，Fragoulis，A.，Sönmez，T. T.，Jahr，H.，Pufe，
T.，& Lippross，S.（2017）. Platelet-released growth factors modulate the secretion of cytokines in synoviocytes under inflammatory joint
disease. Mediators of Inflammation，2017，1–9.
[14]Hassanien，M.，Elawamy，A.，Kamel，E. Z.，Khalifa，W. A.，Abolfadl，G. M.，Roushdy，A. S. I.，El Zohne，R. A.，& Makarem，
Y. S.（2020）. Perineural platelet-rich plasma for diabetic neuropathic pain，could it make a difference? Pain Medicine，21，757–765.
[15]Correa López，J.，Cortés，H.，García Ceballos，E.，& Quintero Pizarro，L.（2017）. Platelet-rich plasma in treating peripheral
neuropathic pain. Preliminary report. Revista De La Sociedad Española Del Dolor，25，263–270.
[16]Shmagel A，Foley R，Ibrahim H. Epidemiology of chronic low back pain in US adults：data from the 2009-2010 National Health and
Nutrition Examination Survey. Arthritis Care Res.2016；68：1688–94
[17]Hestbaek L，Leboeuf-Yde C，Manniche C. Is low back pain part of a general health pattern or is it a separate and distinctive entity?
A critical literature review of comorbidity with low back pain. J Manip Physiol Ther. 2003；26：243–52.
[18]Theis KA，Roblin DW，Helmick CG，Luo R. Prevalence and causes of work disability among working-age U.S. adults，2011–2013，
NHIS. Disabil Health J. 2018；11：108–15
[19]Stewart WF，Ricci JA，Chee E，Morganstein D，Lipton R. Lost productive time and cost due to common pain conditions in the US
workforce. JAMA.2003；290：2443–54
[20]Sullivan MJ，Reesor K，Mikail S，Fisher R. The treatment of depression in chronic low back pain：review and recommendations. Pain.
1992；50：5–13.][Porter LS，Keefe FJ，Wellington C，de Williams A. Pain communication in the context of osteoarthritis：patient and
partner selfefficacy for pain communication and holding back from discussion of pain and arthritis-related concerns. Clin J Pain. 2008；
24：662–8
[21]Mohammed S，Yu J. Platelet-rich plasma injections：an emerging therapy for chronic discogenic low back pain. J Spine Surg. 2018；
4：115–22
[22]Monfett M，Harrison J，Boachie-Adjei K，Lutz G. Intradiscal platelet-rich plasma（PRP）injections for discogenic low back pain：
an update. Int Orthop International Orthopaedics；2016；40：1321–8.
[23]Levi D，Horn S，Tyszko S，Levin J，Hecht-Leavitt C，Walko E. Intradiscal platelet-rich plasma injection for chronic discogenic lowback pain：preliminary results from a prospective trial. Pain Med.2015；17：pnv053
[24]Simopoulos TT，Manchikanti L，Gupta S，Aydin SM，Kim CH，Solanki D，et al. Systematic review of the diagnostic accuracy and
therapeutic effectiveness of sacroiliac joint interventions. Pain Physician.2015；18：E713–56
[25]Singla V，Batra YK，Bharti N，Goni VG，Marwaha N. Steroid vs. platelet-rich plasma in ultrasound-guided sacroiliac joint injection
for chronic low back pain. Pain Pract. 2017；17：782–91.][Ko GD，Mindra S，Lawson GE，Whitmore S，Arseneau L. Case series of
ultrasound-guided platelet-rich plasma injections for sacroiliac joint dysfunction. J Back Musculoskelet Rehabil. 2017；30：363–70.
[26]Ko GD，Mindra S，Lawson GE，Whitmore S，Arseneau L. Case series of ultrasound-guided platelet-rich plasma injections for
sacroiliac joint dysfunction. J Back Musculoskelet Rehabil. 2017；30：363–70
[27][Bruyère O，Honvo G，Veronese N，et al. An updated algorithm recommendation for the management of knee osteoarthritis from the
European Society for Clinical and Economic Aspects of Osteoporosis，Osteoarthritis and Musculoskeletal Diseases（ESCEO）. Semin
Arthritis Rheum 2019；49：337-50
[28]Singh VK，Rathore KS，Khan G，et al. Clinical and Radiological Study of Serum Fluoride in Relation to Knee Osteoarthritis. Malays
Orthop J 2020；14：151-4
[29]Katz JN，Arant KR，Loeser RF. Diagnosis and Treatment of Hip and Knee Osteoarthritis：A Review. JAMA 2021；325：568-78.
[30]Vitaloni M，Botto-van Bemden A，Sciortino Contreras RM，et al. Global management of patients with knee osteoarthritis begins with
quality of life assessment：a systematic review. BMC Musculoskelet Disord 2019；20：493.
[31]Alfieri FM，Lima ARS，Salgueiro MMHAO，et al. Efficacy of an exercise program combined with lifestyle education in patients with
knee osteoarthritis. Acta Reumatol Port 2020；45：201-6
[32]Belk JW，Kraeutler MJ，Houck DA，et al. Platelet-Rich Plasma Versus Hyaluronic Acid for Knee Osteoarthritis：A Systematic
Review and Meta-analysis of Randomized Controlled Trials. Am J Sports Med 2021；49：249-60
[33]Poniatowski LA，Wojdasiewicz P，Gasik R，et al. Transforming growth factor Beta family：insight into the role of growth factors in
regulation of fracture healing biology and potential clinical applications. Mediators Inflamm 2015；2015：137823.
[34]Guillibert C，Charpin C，Raffray M，et al. Single Injection of High Volume of Autologous Pure PRP Provides a Significant
Improvement in Knee Osteoarthritis：A Prospective Routine Care Study. Int J Mol Sci 2019；20：1327.
[35]Al-Ajlouni J，Awidi A，Samara O，et al. Safety and Efficacy of Autologous Intra-articular Platelet Lysates in Early and Intermediate
Knee Osteoarthrosis in Humans：A Prospective Open-Label Study. Clin J Sport Med 2015；25：524-8
[36]Gilat R，Haunschild ED，Knapik DM，et al. Hyaluronic acid and platelet-rich plasma for the management of knee osteoarthritis. Int
Orthop 2021；45：345-54
[37]Luo P，Xiong Z，Sun W，et al. How to Choose PlateletRich Plasma or Hyaluronic Acid for the Treatment of Knee Osteoarthritis in
Overweight or Obese Patients：A Meta-Analysis. Pain Res Manag 2020；2020：7587936.
(8 摘要 Views, 6 PDF Downloads)
Refbacks
- 当前没有refback。